0001209191-23-053004.txt : 20231017
0001209191-23-053004.hdr.sgml : 20231017
20231017184059
ACCESSION NUMBER: 0001209191-23-053004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231016
FILED AS OF DATE: 20231017
DATE AS OF CHANGE: 20231017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gupta Rishi
CENTRAL INDEX KEY: 0001537370
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231330587
MAIL ADDRESS:
STREET 1: C/O CHEMOCENTRYX, INC.
STREET 2: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Turnstone Biologics Corp.
CENTRAL INDEX KEY: 0001764974
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 832909368
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 920 BROADWAY
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 347-897-5988
MAIL ADDRESS:
STREET 1: 920 BROADWAY
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-16
0
0001764974
Turnstone Biologics Corp.
TSBX
0001537370
Gupta Rishi
C/O TURNSTONE BIOLOGICS CORP.
9310 ATHENA CIRCLE, SUITE 300
LA JOLLA
CA
92037
1
0
1
0
0
Stock Option (Right to Buy)
2.61
2023-10-16
4
A
0
25540
0.00
A
2033-10-15
Common Stock
25540
25540
D
Thirty three and thirty three one hundreds percent (33.33%) (and thirty three and thirty four one hundreds percent (33.34%) for year three) of the shares subject to the option will vest in three (3) annual installments commencing on the date of the first annual general meeting of stockholders occurring after October 12, 2023, subject to the Reporting Person's continuous service through each such vesting date.
Pursuant to an agreement between OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefits thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP.
/s/ P. Joseph Campisi, Jr., Attorney-in-Fact
2023-10-17